Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. ASC024

   PEG - Paul-Ehrlich-Gesellschaft für Chemotherapie e. V.

   Michael Kresken, Rheinbach, Germany

   22 April 2017

   Session: Affiliated Societies Corner 2017

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   ePoster presentation

   Other

2. EP0077

   Multidrug resistance to oral antibiotics in Escherichia coli urine isolates from outpatients in Germany and in vitro activity of nitroxoline: results of the PEG 2013 study

   Michael Kresken, Rheinbach, Germany

   M. Kresken, B. Körber-Irrgang, D. Hafner, W. of the Paul-Ehrlich-Society for Chemotherapy

   11 April 2016

   Session: Escherichia coli: diverse, complex, evolving

   Relevance:

    

   100%

    

   

   Event: ECCMID 2016
   Amsterdam, The Netherlands
   ePoster presentation

   Bacterial Susceptibility & Resistance

3. eP179

   In vitro activity of ceftaroline against Staphylococcus aureus using concentrations achieved in humans determined by time-kill methodology

   Michael Kresken, Rheinbach, Germany

   Kresken, M.(1)*; Körber-Irrgang, B.(1);

   10 May 2014

   Session: Antibacterial drug activity and interactions in Gram-positive organisms

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Bacterial Susceptibility & Resistance